Founded at Imperial Collge London, Sprout three years ago, Sprout.ai has now secured $11m in a series A round led by Octopus Ventures.

The genome sequencing technology provider has boosted its total funding to approximately $124m, Sinopharm and China General Technology Group having backed a $38.7m round.

Advancing Harvard Medical School research, Dyno Therapeutics has raised $100m to advance its gene therapies based on AAV.

China Life Healthcare Fund and Venus Medtech have taken part in a round for the heart valve treatment developer sized in the hundreds of millions of dollars.

GV was among the investors in a series A round led by Andreessen Horowitz closed three years after the gene therapy developer's launch.

Nvidia participated in a round valuing the data storage technology provider, which counts Dell, Siemens and Mellanox as investors, at $3.7bn.

The Atrium Health-backed clinical trial software provider increased its overall funding to over $88m in a round led by Insight Partners.

Genetic sequencing platform developer TwinStrand has secured $50m in a series B round led by Section 32, while Alexandria Venture Investments invested for a third time.

Hella and Susquehanna International Group both took part in a series B round that increased the radar technology developer's overall funding to $75m.